SEC Form 4 · accession 0001209191-16-097984
CRESCENT BIOPHARMA, INC. · CBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Franklin H Top Jr.
Director
Period of report
Feb 5, 2016
Accepted (ET)
Feb 12, 2016 · 3:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001253689
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 5, 2016 | M | 11,689 | $1.12 | A | 12,294 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.12 | Feb 5, 2016 | M | 605 | D | — | Sep 20, 2016 | Common Stock | 605 | 0 | D |
| Stock Option (right to buy)F2 | $1.12 | Feb 5, 2016 | M | 11,084 | D | — | Jan 4, 2021 | Common Stock | 11,084 | 0 | D |
Explanation of responses
- F125% of the shares underlying this option vested on September 20, 2007 and the remaining 75% vested in 36 equal monthly installments thereafter.
- F225% of the shares underlying this option vested on January 4, 2012 and the remaining 75% vested in 36 equal monthly installments thereafter.